Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
FIRALIS has developed BIOPRED panel to better target inflammatory autoimmune diseases
CP Wire
Mon, 06/11/18 - 10:14 am
Firalis
MRNA
Biopred Immuno-Inflammatory panel
RNA profiling
autoimmune disease
R&D
personalized medicine
FIRALIS has developed BIOPRED panel to better target inflammatory autoimmune diseases
Mon, 06/11/18 - 10:12 am
Firalis
MRNA
Biopred Immuno-Inflammatory panel
RNA profiling
autoimmune disease
R&D
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
Xconomy
Mon, 06/11/18 - 09:54 am
MRNA
Sanofi
Translate Bio
vaccines
R&D
Medical Device Excise Tax Reduces R&D Spending Among Companies
Xtalks
Mon, 06/11/18 - 09:50 am
devices
device tax
R&D
Affordable Care Act
A Story Of Devastation And Rebirth -- The Former Pfizer Research Labs In Ann Arbor
Forbes
Mon, 06/11/18 - 09:34 am
Pfizer
Torcetrapib
R&D
Lipitor
Servier opens Kendall Square site, plans Chinese office to access external innovation
Fierce Biotech
Thu, 06/7/18 - 11:00 pm
Servier
Kendall Square
Boston
Biogen
R&D
Study: Med device excise tax cost medtech R&D $34m
Mass Device
Thu, 06/7/18 - 10:40 pm
devices
device tax
R&D
Affordable Care Act
Pfizer adds $600M to its venture group, with a special focus on the neurosciences field it just retreated from
Endpoints
Wed, 06/6/18 - 11:29 am
Pfizer
Neurosciences
R&D
venture funds
With $1.2B NASH deal behind them, Nimbus raises $65M for I/O, other R&D
Endpoints
Tue, 06/5/18 - 10:33 am
Nimbus
R&D
immuno-oncology
Bayer scrutinizes R&D group’s productivity as staffers fear layoffs in wake of a revamp
Endpoints
Thu, 05/31/18 - 09:58 pm
Bayer
layoffs
R&D
Top research execs from Teva, Allergan recruited to help lead Axovant out of the R&D wasteland
Endpoints
Tue, 05/29/18 - 08:57 am
Axovant Sciences
R&D
Allergan
Teva Pharmaceutical
After AL amyloidosis flop, Prothena slashes workforce by 57%
Fierce Biotech
Fri, 05/25/18 - 10:08 am
Prothena
R&D
Celgene
AL amyloidosis
layoffs
Cleveland Clinic launches new biorepository
Biopharma Dive
Thu, 05/24/18 - 12:01 pm
Cleveland Clinic
biorepository
R&D
Astellas shedding 600-plus jobs as CEO shakes up R&D and sales ops in restructuring
Endpoints
Wed, 05/23/18 - 12:02 pm
Astellas
layoffs
R&D
sales
restructuring
Kenji Yasukawa
Will Shire’s top R&D talent bolt now that Takeda has struck a merger agreement?
Endpoints
Thu, 05/17/18 - 11:57 am
Shire
Takeda
M&A
R&D
Foundation Medicine Launches Gene Expression Profiling Program to Aid in Development of Personalized Cancer Therapy
CP Wire
Wed, 05/2/18 - 09:59 am
Foundation Medicine
gene expression profiling
R&D
personalized medicine
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
CP Wire
Wed, 05/2/18 - 09:58 am
NeoImmune Tech
Genexine
Roche
R&D
melanoma
Merkel cell carcinoma
cutaneous squamous cell carcinoma
Zoetis doubles down on animal vaccines
Biopharma Dive
Mon, 04/30/18 - 09:33 am
Zoetis
China
animal health
R&D
vaccines
GSK boss rethinking R&D incentives, as Barron and Sin seek out early and late-stage ops
Fierce Biotech
Wed, 04/25/18 - 01:07 pm
GSK
R&D
Emma Walmsley
Sanofi hires ex-Roche executive John Reed to replace retiring Elias Zerhouni as R&D chief
Fierce Biotech
Tue, 04/24/18 - 09:29 am
Sanofi
R&D
Elias Zerhouni
Pages
« first
‹ previous
…
36
37
38
39
40
41
42
43
44
…
next ›
last »